Summary
For Year 2026-27, Kwality Pharmaceuticals reports the following shareholding: Total Promoters at 54.87%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 2.79%, Domestic Institutional Investors at 0.36%, and Retail at 41.98%. This breakdown provides a quick snapshot of ownership distribution for Kwality Pharmaceuticals in 2026-27.
Kwality Pharmaceuticals FAQs
As of 05-2026, the promoter shareholding in Kwality Pharmaceuticals stands at 54.87% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Kwality Pharmaceuticals is 2.79% and 0.36% respectively.
The retail shareholding of the Kwality Pharmaceuticals is 41.98%.
Changes in shareholding patterns of Kwality Pharmaceuticals can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Kwality Pharmaceuticals are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
Kwality Pharmaceuticals Associated Pages
